DSS
Earnings company data as of 4:48 AM ET 10/23
Limited consensus data for this ticker (thin coverage or data-plan limits).
Dates may be company-announced rather than sell-side consensus.
Calendar and recent prints remain the primary lens when available.
Scheduled
2 periods, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 13 Nov | EPS | — | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 14 Aug | EPS | — | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by DSS's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $18K sold by 1 insider outside a trading plan
- None no planned (10b5-1) sales
-
Heng Fai Ambrose Chan DirectorSale$18K 21,852 shares at $0.8200 2.1% of stakeTraded Sep 3 Filed Sep 8
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| DEF 14A | Filing Doc | ||
| 8-K | 1.01,9.01 | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 424B5 | Filing Doc | ||
| 10-Q | Filing Doc | ||
| SCHEDULE 13D/A | — | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| S-1/A | Filing Doc | ||
| S-1 | Filing Doc | ||
| 10-K | Filing Doc | ||
| 8-K | 1.01,9.01 | Filing Doc | |
| 424B5 | Filing Doc | ||
| 8-K | 1.01,8.01,9.01 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 10-Q | Filing Doc | ||
| DEF 14A | Filing Doc | ||
| SCHEDULE 13D/A | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 1.01,9.01 | Filing Doc | |
| 8-K | 4.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 10-K | Period Dec 31, 2024 | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.